SYGNOMICS aims to help clinicians improve patient outcomes at scale by accurately applying systems biology to cancer care. SYGNOMICS is developing an end-to-end solution that uses a unique and disruptive approach to enable personalized precision medicine for cancer patients. This solution will be powered by the Systems Genetics Network AnaLysis (SYGNAL) technology, which can accurately risk stratify a patient and personalize therapies (drugs and drug combinations) based on the unique characteristics of transcriptional “programs” underlying their disease.
| Website | http://sygnomics.net |
| Employees | 13 (4 on RocketReach) |
| Founded | 2020 |
| Industry | Hospitals and Health Care |
| Keywords | Oncology, Precision Medicine, Systems Biology, Personalized Medicine, Genomics, Cancer Care, Patient Outcomes, Bioinformatics, Biotechnology, Drug Discovery, Proteomics, Clinical Trials, Therapeutics, Data Analytics, Medical Technology, Big Data, Healthcare, Artificial Intelligence, Machine Learning |
| Competitors | Exact Sciences, Guardant Health, Myriad Genetics, Foundation Medicine, NantHealth, Freenome, Genomic Health, Inventiva Pharma, Biocept, Inc., carisls +38 more (view full list) |
Looking for a particular Sygnomics employee's phone or email?
Sygnomics Questions
Ashutosh Tiwary is the Co-Founder and CEO of Sygnomics.
4 people are employed at Sygnomics.
Top Sygnomics Employees
-
Ashutosh Tiwary
Co-Founder and CEO at Sygnomics
Bellevue, WA, US25+ -
Thomas Brown
Chief Medical Officer at Sygnomics
Seattle, WA, US25+ -
33
-
Natalie Brown
Intern at Sygnomics
Seattle, WA, US
